Google-backed Isomorphic raises $2.1 billion to scale AI-driven drug discovery - Reuters
Google-backed Isomorphic raises $2.1 billion to scale AI-driven drug discovery Reuters
Community feed
A focused stream of recent stories from the sources curated for this community. Latest: Google-backed Isomorphic raises $2.1 billion to scale AI-driven drug discovery - Reuters, Nvidia stock edges lower as US export restrictions on AI chip sales weigh on sentiment - Traders Union, and Bounteous Acquires Cartesian to Expand Enterprise AI and Data Analytics Capabilities - citybiz. Page 113.
Google-backed Isomorphic raises $2.1 billion to scale AI-driven drug discovery Reuters
Nvidia stock edges lower as US export restrictions on AI chip sales weigh on sentiment Traders Union
Bounteous Acquires Cartesian to Expand Enterprise AI and Data Analytics Capabilities citybiz
IBM well-positioned to benefit from enterprise AI demand Proactive financial news
OpenAI CEO Sam Altman has taken the stand in a high-profile trial pitting him against cofounder Elon Musk.
Apaleo and Cocoon Hotels Announce Launch of AI Agent for Room Allocation LODGING Magazine
Is Anthropic’s New A.I. Really That Scary? It Depends Whom You Ask. The New York Times
Authorities say she asked ChatGPT about mixing alcohol and medication. Then, two men turned up dead. NBC News
RSL Media is launching a new AI licensing standard backed by Tom Hanks, George Clooney, and Meryl Streep, which will allow people to set terms for how AI systems can use their creative works or likenesses.
Governed enterprise AI drives IBM’s strategy SiliconANGLE
Running a Local LLM on a 12-year-old Raspberry Pi 1 Adafruit
‘Are you completely trustworthy?’: Musk’s attorney presses OpenAI CEO in trial CNN
More stories load automatically as you scroll.